Impella RP Flex with SmartAssist
Abiomed, Inc. · Decision date Oct 26, 2026
What did the FDA decide?
The FDA record P170011/S064 is a 30-day notice for the Impella RP Flex with SmartAssist, listed as a temporary non-roller type right heart support blood pump under product code PYX, submitted by Abiomed, Inc. Its stated purpose is to add a supplier for the RP outflow cage. The listed reason is a process change covering manufacturer, sterilizer, packager or supplier.
The record does not identify the new supplier, describe the cage material or specifications, or state what verification supported the change. The identifier places it as supplement S064 to PMA P170011, so it concerns that approved device rather than an original approval or a new indication. The reported purpose is a manufacturing change, not independent evidence of safety or clinical effectiveness.
FDA approval order statement
to add a supplier for the RP outflow cage
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 26, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P170011/S064
- Regulatory pathway
- PMA supplement
- Applicant
- Abiomed, Inc.
- Product code
- PYX
- Decision code
- OK30
- Decision date
- Oct 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Temporary non-roller type right heart support blood pump.
- Applicant
- Abiomed, Inc.
- Product code
- PYX
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P170011. Subsequent supplements may change the device or its indications.
FDA decision timeline
P170011 · Original PMA
Impella RP System
P170011/S064 received
Application receipt date recorded by FDA.
P170011/S064 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P170011. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170011
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Impella RP SystemP170011 | Abiomed, Inc. | PMA approval | Sep 20, 2017 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abiomed, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 22 Cherry Hill Dr., Danvers, MA, 01923
Sources and methodology
- Original FDA record: P170011/S064
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records